Patients with serious or life-threatening diseases or conditions sometimes seek medical products that are not yet approved or available in their country. Novartis “Managed Access” addresses this need by making certain investigational or unapproved treatments available to eligible patients.

Learn more -> https://www.novartis.com/our-focus/healthcare-professionals/managed-acce... [2]